Literature DB >> 10594071

Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats.

Z G Zhang1, M Chopp, A Goussev, D Lu, D Morris, W Tsang, C Powers, K L Ho.   

Abstract

The mechanisms underlying cerebral microvascular perfusion deficit resulting from occlusion of the middle cerebral artery (MCA) require elucidation. We, therefore, tested the hypothesis that intravascular fibrin deposition in situ directly obstructs cerebral microcirculation and that local changes in type 1 plasminogen activator inhibitor (PAI-1) gene expression contribute to intravascular fibrin deposition after embolic MCA occlusion. Using laser-scanning confocal microscopy (LSCM) in combination with immunofluorescent staining, we simultaneously measured in three dimensions the distribution of microvascular plasma perfusion deficit and fibrin(ogen) immunoreactivity in a rat model of focal cerebral embolic ischemia (n = 12). In addition, using in situ hybridization and immunostaining, we analyzed expression of PAI-1 in ischemic brain (n = 13). A significant (p < 0.05) reduction of cerebral microvascular plasma perfusion accompanied a significant (p < 0.05) increase of intravascular and extravascular fibrin deposition in the ischemic lesion. Microvascular plasma perfusion deficit and fibrin deposition expanded concomitantly from the subcortex to the cortex during 1 and 4 hr of embolic MCA occlusion. Three-dimensional analysis revealed that intravascular fibrin deposition directly blocks microvascular plasma perfusion. Vascular plugs contained erythrocytes, polymorphonuclear leukocytes, and platelets enmeshed in fibrin. In situ hybridization demonstrated induction of PAI-1 mRNA in vascular endothelial cells in the ischemic region at 1 hr of ischemia. PAI-1 mRNA significantly increased at 4 hr of ischemia. Immunohistochemical staining showed the same pattern of increased PAI-1 antigen in the endothelial cells. These data demonstrate, for the first time, that progressive intravascular fibrin deposition directly blocks cerebral microvascular plasma perfusion in the ischemic region during acute focal cerebral embolic ischemia, and upregulation of the PAI-1 gene in the ischemic lesion may foster fibrin deposition through suppression of fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594071      PMCID: PMC6784928     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Temporal impairment of microcirculatory perfusion following focal cerebral ischemia in the spontaneously hypertensive rat.

Authors:  D A Dawson; C A Ruetzler; J M Hallenbeck
Journal:  Brain Res       Date:  1997-02-28       Impact factor: 3.252

Review 2.  Basic and clinical aspects of fibrinolysis and thrombolysis.

Authors:  D Collen; H R Lijnen
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

3.  Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke.

Authors:  Q Jiang; R L Zhang; Z G Zhang; J R Ewing; P Jiang; G W Divine; R A Knight; M Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2000-01       Impact factor: 6.200

4.  Neuroserpin, an axonally secreted serine protease inhibitor.

Authors:  T Osterwalder; J Contartese; E T Stoeckli; T B Kuhn; P Sonderegger
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

5.  Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex.

Authors:  J H Garcia; K F Liu; K L Ho
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

6.  Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat).

Authors:  J H Garcia; K F Liu; Y Yoshida; S Chen; J Lian
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  Hypoxia increases velocity of blood flow through parenchymal microvascular systems in rat brain.

Authors:  D Bereczki; L Wei; T Otsuka; V Acuff; K Pettigrew; C Patlak; J Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1993-05       Impact factor: 6.200

8.  Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats.

Authors:  W D Heiss; R Graf; K Wienhard; J Löttgen; R Saito; T Fujita; G Rosner; R Wagner
Journal:  J Cereb Blood Flow Metab       Date:  1994-11       Impact factor: 6.200

9.  Microthromboemboli in acute infarcts: analysis of 40 autopsy cases.

Authors:  N Heye; J Cervos-Navarro
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

10.  Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis.

Authors:  A R Kitching; S R Holdsworth; V A Ploplis; E F Plow; D Collen; P Carmeliet; P G Tipping
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  33 in total

1.  Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke.

Authors:  Kiat T Tan; Gregory Y H Lip
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 2.  The neurovascular unit and combination treatment strategies for stroke.

Authors:  Li Zhang; Zheng Gang Zhang; Michael Chopp
Journal:  Trends Pharmacol Sci       Date:  2012-05-16       Impact factor: 14.819

3.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

4.  PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Authors:  Rong Jin; Adam Y Xiao; Jarvis Li; Min Wang; Guohong Li
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

5.  MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.

Authors:  G Ding; Z Zhang; M Chopp; L Li; L Zhang; Q Li; M Wei; Q Jiang
Journal:  Neuroscience       Date:  2014-04-24       Impact factor: 3.590

6.  Increased volumes of mildly elevated capillary transit time heterogeneity positively predict favorable outcome and negatively predict intracranial hemorrhage in acute ischemic stroke with large vessel occlusion.

Authors:  A Potreck; S Loebel; J Pfaff; L Østergaard; K Mouridsen; A Radbruch; M Bendszus; S Mundiyanapurath
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

7.  Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke.

Authors:  Longfei Jia; Michael Chopp; Li Zhang; Mei Lu; Zhenggang Zhang
Journal:  Stroke       Date:  2010-07-29       Impact factor: 7.914

8.  Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.

Authors:  Rong Jin; Adam Y Xiao; Shan Liu; Min Wang; Guohong Li
Journal:  Stroke       Date:  2018-05-29       Impact factor: 7.914

9.  Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke.

Authors:  Rui Lan Zhang; Chunling Zhang; Li Zhang; Cindi Roberts; Mei Lu; Alissa Kapke; Yisheng Cui; Mitsuyoshi Ninomiya; Toshiaki Nagafuji; Bruce Albala; Zheng Gang Zhang; Michael Chopp
Journal:  Stroke       Date:  2008-07-31       Impact factor: 7.914

10.  Dual-color fluorescence imaging in a nude mouse orthotopic glioma model.

Authors:  Xuepeng Zhang; Xuguang Zheng; Feng Jiang; Zheng Gang Zhang; Mark Katakowski; Michael Chopp
Journal:  J Neurosci Methods       Date:  2009-05-15       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.